Jennifer E Payne MD
Hematology /Medical Oncology at Summa Health Medical Group
Join to view full profile
1900 23rd StCuyahoga Falls, OH 44223
Phone+1 330-971-7892
Fax+1 330-926-5870
Dr. Payne is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1997 - 2000
University of Pittsburgh School of MedicineClass of 1997
Certifications & Licensure
OH State Medical License 2000 - 2028
CT State Medical License 2006 - 2019
FL State Medical License 2014 - 2018
CA State Medical License 2013 - 2017
WV State Medical License 2013 - 2015
PA State Medical License 1997 - 2000
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
Publications & Presentations
PubMed
- 6 citationsE4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine TumorsSam J. Lubner, Yang Feng, Mary F. Mulcahy, Peter O'Dwyer, Guang Yu Giang
The Oncologist. 2018-09-01 - 18 citationsHigh-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an e...Punit D. Wadhwa, Pingfu Fu, Omer N. Koc, Brenda W. Cooper, R. M. Fox
Biology of Blood and Marrow Transplantation. 2005-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
